Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?

Blood Coagul Fibrinolysis. 2004 Mar;15(2):129-30. doi: 10.1097/00001721-200403000-00003.

Authors

Wai Khoon Ho¹, Graeme J Hankey, John W Eikelboom

Affiliation

¹ Centre for Clinical Research Excellence, Department of Neurology and Department of Haematology, Royal Perth Hospital, Australia and School of Medicine and Pharmacology, University of Western Australia, Australia.

PMID: 15090999
DOI: 10.1097/00001721-200403000-00003

No abstract available

Publication types

Comment

MeSH terms

Aspirin / pharmacology
Aspirin / therapeutic use*
Clinical Laboratory Techniques
Drug Resistance*
Humans
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / pharmacology
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Function Tests / instrumentation
Risk
Treatment Failure

Substances

Platelet Aggregation Inhibitors
Aspirin